On the origin of chemical species

Organic chemist Dan Lednicer has provided us with a guest Sciencebase editorial. “The enormous strides that have recently been made in molecular biology hold great promise for speeding the discovery of pharmaceuticals to treat diseases that have so far been recalcitrant to drug therapy,” he explains, “and the day may well be in the offing when a majority of important new pharmaceutical products will owe their existence to carefully crafted research programs based on the increasingly detailed understanding of the molecular biology involved in the particular disease that is being addressed.

Read the full feature from Dr Lednicer here in Serendipity and Science